These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9212049)

  • 1. High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation.
    Verrier CS; Roodi N; Yee CJ; Bailey LR; Jensen RA; Bustin M; Parl FF
    Mol Endocrinol; 1997 Jul; 11(8):1009-19. PubMed ID: 9212049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
    Zhang CC; Krieg S; Shapiro DJ
    Mol Endocrinol; 1999 Apr; 13(4):632-43. PubMed ID: 10194768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of an estrogen-responsive element binding protein repressed by estradiol.
    Gray WG; Gorski J
    Biochemistry; 1996 Sep; 35(36):11685-92. PubMed ID: 8794749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression.
    Klinge CM; Silver BF; Driscoll MD; Sathya G; Bambara RA; Hilf R
    J Biol Chem; 1997 Dec; 272(50):31465-74. PubMed ID: 9395481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer.
    Foster BD; Cavener DR; Parl FF
    Cancer Res; 1991 Jul; 51(13):3405-10. PubMed ID: 2054780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes.
    Huang J; Li X; Yi P; Hilf R; Bambara RA; Muyan M
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):65-78. PubMed ID: 15130512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mobility group protein 1 interacts specifically with the core domain of human TATA box-binding protein and interferes with transcription factor IIB within the pre-initiation complex.
    Sutrias-Grau M; Bianchi ME; Bernués J
    J Biol Chem; 1999 Jan; 274(3):1628-34. PubMed ID: 9880542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
    McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
    Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters.
    Nardulli AM; Romine LE; Carpo C; Greene GL; Rainish B
    Mol Endocrinol; 1996 Jun; 10(6):694-704. PubMed ID: 8776729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of estrogen- and thyroid hormone receptors on a progesterone receptor estrogen response element (ERE) sequence: a comparison with the vitellogenin A2 consensus ERE.
    Scott RE; Wu-Peng XS; Yen PM; Chin WW; Pfaff DW
    Mol Endocrinol; 1997 Oct; 11(11):1581-92. PubMed ID: 9328341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1).
    Krieg SA; Krieg AJ; Shapiro DJ
    Mol Endocrinol; 2001 Nov; 15(11):1971-82. PubMed ID: 11682627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAF(II)170 interacts with the concave surface of TATA-binding protein to inhibit its DNA binding activity.
    Pereira LA; van der Knaap JA; van den Boom V; van den Heuvel FA; Timmers HT
    Mol Cell Biol; 2001 Nov; 21(21):7523-34. PubMed ID: 11585931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of HMG-1 and adenovirus oncoprotein E1A on early stages of transcriptional preinitiation complex assembly.
    Lu W; Peterson R; Dasgupta A; Scovell WM
    J Biol Chem; 2000 Nov; 275(45):35006-12. PubMed ID: 10882737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression.
    Porter W; Wang F; Wang W; Duan R; Safe S
    Mol Endocrinol; 1996 Nov; 10(11):1371-8. PubMed ID: 8923463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA binding site selection by RNA polymerase II TAFs: a TAF(II)250-TAF(II)150 complex recognizes the initiator.
    Chalkley GE; Verrijzer CP
    EMBO J; 1999 Sep; 18(17):4835-45. PubMed ID: 10469661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity.
    Das D; Peterson RC; Scovell WM
    Mol Endocrinol; 2004 Nov; 18(11):2616-32. PubMed ID: 15256536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha requires no accessory factors for high-affinity binding to a consensus response element.
    Anderson I; Bartley CR; Lerch RA; Gray WG; Friesen PD; Gorski J
    Biochemistry; 1998 Dec; 37(49):17287-98. PubMed ID: 9860843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.